Next Article in Journal
A Cross-Sectional Study of Nutrient Intake and Health Status among Older Adults in Yogyakarta Indonesia
Next Article in Special Issue
Is Trabecular Bone Score Valuable in Bone Microstructure Assessment after Gastric Bypass in Women with Morbid Obesity?
Previous Article in Journal
In Vitro Fermentation Patterns of Rice Bran Components by Human Gut Microbiota
Previous Article in Special Issue
Relationship between the Nutritional Status of Vitamin A per Trimester of Pregnancy with Maternal Anthropometry and Anemia after Roux-en-Y Gastric Bypass
Open AccessReview

Pancreatic Exocrine Insufficiency after Bariatric Surgery

1
Center for Digestive Diseases, Karolinska University Hospital, SE-141 86 Stockholm, Sweden
2
Digestive and Liver Disease UnitSant' Andrea Hospital, Sapienza University of Rome, 116 91 Rome, Italy
3
Department of Clinical Science, Danderyd Hospital, Karolinska Institutet and Department of Surgery, Ersta Hospital, SE-116 91 Stockholm, Sweden
*
Author to whom correspondence should be addressed.
Nutrients 2017, 9(11), 1241; https://doi.org/10.3390/nu9111241
Received: 28 September 2017 / Revised: 8 November 2017 / Accepted: 10 November 2017 / Published: 13 November 2017
(This article belongs to the Special Issue Nutrition and Bariatric Surgery)
Morbid obesity is a lifelong disease, and all patients require complementary follow-up including nutritional surveillance by a multidisciplinary team after bariatric procedures. Pancreatic exocrine insufficiency (PEI) refers to an insufficient secretion of pancreatic enzymes and/or sodium bicarbonate. PEI is a known multifactorial complication after upper gastrointestinal surgery, and might constitute an important clinical problem due to the large number of bariatric surgical procedures in the world. Symptoms of PEI often overlap with sequelae of gastric bypass, making the diagnosis difficult. Steatorrhea, weight loss, maldigestion and malabsorption are pathognomonic for both clinical conditions. Altered anatomy after bypass surgery can make the diagnostic process even more difficult. Fecal elastase-1 (FE1) is a useful diagnostic test. PEI should be considered in all patients after bariatric surgery with prolonged gastrointestinal complaints that are suggestive of maldigestion and/or malabsorption. Appropriate pancreatic enzyme replacement therapy should be part of the treatment algorithm in patients with confirmed PEI or symptoms suggestive of this complication. View Full-Text
Keywords: pancreas; exocrine; insufficiency; obesity; bariatric surgery pancreas; exocrine; insufficiency; obesity; bariatric surgery
Show Figures

Figure 1

MDPI and ACS Style

Vujasinovic, M.; Valente, R.; Thorell, A.; Rutkowski, W.; Haas, S.L.; Arnelo, U.; Martin, L.; Löhr, J.-M. Pancreatic Exocrine Insufficiency after Bariatric Surgery. Nutrients 2017, 9, 1241.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop